Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B

Seung In Seo1, Hyoung Su Kim1, Bo Kyung Yang1

  • 1Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Sungnae-gil, Kangdong-gu, Seoul, Republic of Korea 134-701.

Insights

Cirrhosis and elevated ALT levels are key predictors of hepatocellular carcinoma (HCC) in immune inactive chronic hepatitis B (CHB). Closer monitoring is recommended for CHB patients with these risk factors to prevent HCC development.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Risk factors for hepatocellular carcinoma (HCC) in immune inactive chronic hepatitis B (CHB) remain unclear.
  • Understanding these factors is crucial for early detection and prevention strategies.

Purpose of the Study:

  • To identify predictive factors for HCC development in patients with immune inactive CHB.
  • To clarify the risk associated with specific clinical and biochemical markers.

Main Methods:

  • A cohort of 337 patients with immune inactive CHB was followed from 1995 to 2017.
  • Univariate and multivariate analyses, including Cox regression, were used to identify independent risk factors.
  • Follow-up averaged 63 months, with HCC incidence recorded.

Main Results:

  • The overall HCC incidence was 4.5% (15/337) during the follow-up period.
  • Independent predictors for HCC were the presence of cirrhosis (HR, 11.768) and ALT elevation >2x ULN (HR, 3.774).
  • Cumulative HCC incidence at 10 years increased significantly with the number of risk factors (6.3% to 63.5%).

Conclusions:

  • Underlying cirrhosis and hepatic inflammation (indicated by ALT elevation) are significant HCC predictors in immune inactive CHB.
  • ALT elevation and cirrhosis have a synergistic effect on HCC development.
  • Patients with high ALT levels, particularly those with cirrhosis, require intensified HCC surveillance.
Abstract

Related Concept Videos

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
477
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
137
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
769